Results 201 to 210 of about 17,128 (260)

Ultrasound-based transient elastography combined with metabolic biomarkers enhances the diagnostic efficacy for pediatric MASLD. [PDF]

Medicine (Baltimore)
Bei Z, Xiao Y, Zuo Z, He J, Wang S, Feng T.   +5 more
europepmc   +1 more source

Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical Heterogeneity, Risk Stratification, and Personalized Care. [PDF]

Clin Exp Gastroenterol
Vo TD.
europepmc   +1 more source

Effect of pemafibrate on LDL‐cholesterol properties in type 2 diabetes and hypertriglyceridemia by lipid management status: PARM‐T2D post hoc analysis

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Although pemafibrate attracts attention for reducing LDL‐C in patients with high baseline LDL‐C, its comprehensive effects remain unclear in patients with type 2 diabetes. This post hoc analysis of the PARM‐T2D study investigated the effects of pemafibrate on LDL‐C concentration and particle size in 156 subjects with type 2 diabetes and ...
Hiroya Kitsunai, Kenichi Kito, Kazuno Omori, Kyu Yong Cho, Akinobu Nakamura, Jun Takeuchi, So Nagai, Ichiro Sakuma, Hiroshi Nomoto   +8 more
wiley   +1 more source

Association Between Serum Magnesium Levels and Metabolic Dysfunction-Associated Steatotic Liver Disease in a Nationally Representative Sample of Korean Adults, 2024. [PDF]

Metabolites
Baek SU, Yoon JH.
europepmc   +1 more source

Gaps in the Cascade of Care Contribute to Poor Liver Cancer Outcomes Among People Living With Hepatitis B: A Multicenter Observational Cohort Study

Journal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background Chronic hepatitis B virus (HBV) remains a major cause of hepatocellular carcinoma (HCC) in Australia, despite the availability of effective, subsidized antiviral therapy. We aimed to describe the clinical characteristics, HBV care cascade, and outcomes among people with HBV‐related HCC in Victoria, Australia.
Dina Moussa, Joan Ericka Flores, Michael Macisaac, Jack Wallace, Joseph Doyle, Marno Ryan, Thai Hong, Brett Knowles, Adrian Fox, Ashu Jhamb, Tom Sutherland, Stuart Roberts, William Kemp, Ammar Majeed, Marie Sinclair, Rohit Sawhney, Stephen Bloom, Amanda Nicoll, Zina Valaydon, Gauri Mishra, Sid Sood, Diana Lewis, A. Thompson, J. Howell   +23 more
wiley   +1 more source

Systems biology framework for the rational design of operational conditions for in vitro/in vivo translation of tissue models. [PDF]

Sci Adv
Cadavid JL, Meimetis N, Matsuzaki T, Tevonian EN, Griffith LG, Lauffenburger DA.   +5 more
europepmc   +1 more source

Hypocholesterolemia in liver and cardiovascular disease: Friend or foe?

Journal of Internal Medicine, EarlyView.
Abstract Hypocholesterolemia is perceived as benign given its association with lower cardiovascular risk. However, genetic and epidemiological evidence indicates that persistently low levels of low‐density lipoprotein cholesterol (LDL‐C) and apolipoprotein B (ApoB) arise from distinct biological mechanisms with different hepatic implications ...
Valentina Flagiello, Emelie Barreby, Umberto Vespasiani‐Gentilucci, Stefano Romeo   +3 more
wiley   +1 more source

Vitamin (B1, B6, B12, D, and Folate) and Mineral (Iron, Selenium, and Magnesium) Status Across the Spectrum of Severe Obesity: An Integrative Multivariate Analysis of Metabolic and Nutritional Profiles. [PDF]

Nutrients
Sabados H, Möwius S, Stern UM, Michel M, Schattenberg JM, Keller V.   +5 more
europepmc   +1 more source

Extracellular Vesicle-Based miRNA Profiling in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Secondary Analysis of the MULTISITE Clinical Trial. [PDF]

J Extracell Biol
Cliff KL, Guanzon D, Lai A, Scholz-Romero K, Christiansen G, Handberg A, Salomon C, Mellergaard M.   +7 more
europepmc   +1 more source

Revisiting Obesity Definitions: Impact of the 2025 Lancet Commission Criteria on Obesity Prevalence Among People With MASLD. [PDF]

Liver Int
Feng Q, Iorra FQ, Manousou P.
europepmc   +1 more source